EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte Studie

Montelukast sodium in preventing oxygen requirements at day 28 in preterm infants: A multicenter randomized controlled trial

Farhad Abolhasan Choobdar, Zahra Soltani, Zahra Vahedi, Arash Mohazzab, Mandana Kashaki, Maryam Saboute, Majid Karoobi, Farhad Mansoori

Journal of Neonatal-Perinatal Medicine · 21.11.2026

DOI: 10.1177/19345798261509586 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Journal of Neonatal-Perinatal Medicine, online erschienen am 21.11.2026. Verfasst von Farhad Abolhasan Choobdar und 7 weiteren Autor:innen. Die Arbeit nennt 22 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Evaluating the efficacy and safety of oral montelukast in preventing oxygen requirement at day 28 of birth in preterm infants admitted to the neonatal intensive care unit through a randomized trial with open-label treatment administration and blinded outcome assessment.

Methods

Target Population: 92 preterm infants admitted to the Neonatal Intensive Care Units of four hospitals.

Intervention

Daily oral administration of 1 mg/kg montelukast. Primary Outcome: Incidence of Oxygen requirement on days 14 and 28 of life.

Results

Reduction in Oxygen requirement: Significantly lower in the intervention group (31.7%) compared to the control group (55%). Lung Disease Severity: Pulmonary Severity Score was significantly lower in the montelukast group on days 14 and 28. Safety Profile: No serious drug-related adverse effects were reported. Secondary Outcomes: No statistically significant differences were observed regarding mortality or length of hospital stay between the two groups.

Conclusion

Preventive administration of montelukast in high-risk preterm infants appears to be safe and effective in reducing the incidence of oxygen requirement at day 28/discharge.

Zitieren

APA

Choobdar, F. A., Soltani, Z., Vahedi, Z., Mohazzab, A., Kashaki, M., Saboute, M., Karoobi, M., & Mansoori, F. (2026). Montelukast sodium in preventing oxygen requirements at day 28 in preterm infants: A multicenter randomized controlled trial. Journal of Neonatal-Perinatal Medicine. https://doi.org/10.1177/19345798261509586

Vancouver

Choobdar FA, Soltani Z, Vahedi Z, Mohazzab A, Kashaki M, Saboute M, et al. Montelukast sodium in preventing oxygen requirements at day 28 in preterm infants: A multicenter randomized controlled trial. Journal of Neonatal-Perinatal Medicine. 2026. doi:10.1177/19345798261509586

BibTeX
@article{Choobdar2026,
  author = {Choobdar, Farhad Abolhasan and Soltani, Zahra and Vahedi, Zahra and Mohazzab, Arash and Kashaki, Mandana and Saboute, Maryam and Karoobi, Majid and Mansoori, Farhad},
  title = {Montelukast sodium in preventing oxygen requirements at day 28 in preterm infants: A multicenter randomized controlled trial},
  journal = {Journal of Neonatal-Perinatal Medicine},
  year = {2026},
  doi = {10.1177/19345798261509586}
}
Kostenlos starten →